Last reviewed · How we verify

Natacyn — Competitive Intelligence Brief

Natacyn (NATAMYCIN) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Polyene Antimicrobial [EPC]. Area: Other.

marketed Polyene Antimicrobial [EPC] Other Small molecule Live · refreshed every 30 min

Target snapshot

Natacyn (NATAMYCIN) — Harrow Health.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Natacyn TARGET NATAMYCIN Harrow Health marketed Polyene Antimicrobial [EPC] 1978-01-01
NATACYN® NATACYN® IVIEW Therapeutics Inc. marketed Polyene Antimicrobial

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Polyene Antimicrobial [EPC] class)

  1. Harrow Health · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Natacyn — Competitive Intelligence Brief. https://druglandscape.com/ci/natamycin. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: